Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-07-24
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main feasibility questions are:
i) To establish recruitment uptake ii) To establish treatment adherence iii) To determine participant retention. Participants will be randomly allocated to the intervention and control group. Those in the intervention group will receive a follow-up telephone call at two weeks after discharge and a second follow-up appointment at six weeks after discharge. Outcome measures will be taken at twelve weeks after discharge.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Stroke Intensive Rehabilitation
NCT03866057
Evaluation of the Feasibility of a Patient-centered Transition Program for Stroke Patients and Their Informal Caregivers, Combining Follow-up by a Case-manager and Access to an Internet Information Platform
NCT05928832
Feasibility of a Stroke Specific Self-management Program
NCT03993574
Technology Enriched Stroke Rehabilitation in Acute/Sub-acute Stroke
NCT05981729
A Rehabilitation Program Based on Daily Activities in Patients With Cerebrovascular Accident
NCT05772663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care
All participants will receive a brief routine stroke medical follow-up appointment.
No interventions assigned to this group
Personalised, holistic based follow-up appointments underpinned by self determination theory.
Participants will receive two follow-up appointments at two and six weeks after discharge.
Personalised, holistic follow-up appointments underpinned by self determination theory
Appointment 1 (two weeks after discharge):
* Address participants knowledge gaps as regards their stroke, medication and secondary prevention.
* Detailed biopsychosocial review.
* Understand participant priorities and jointly set goals.
* Agreeing onward referrals if needed.
* Written summary sent to GP with copy to participant.
Appointment 2 (six weeks):
* Review priorities identified in post stroke review checklist.
* Review goals and plans from first appointment.
* Address any new or persistent information gaps.
* Review hidden impairments that may be impacting on return to work, activities of daily living, relationships or general well-being.
* Agreeing onward referrals and action plan.
* Written summary and plan sent to GP.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalised, holistic follow-up appointments underpinned by self determination theory
Appointment 1 (two weeks after discharge):
* Address participants knowledge gaps as regards their stroke, medication and secondary prevention.
* Detailed biopsychosocial review.
* Understand participant priorities and jointly set goals.
* Agreeing onward referrals if needed.
* Written summary sent to GP with copy to participant.
Appointment 2 (six weeks):
* Review priorities identified in post stroke review checklist.
* Review goals and plans from first appointment.
* Address any new or persistent information gaps.
* Review hidden impairments that may be impacting on return to work, activities of daily living, relationships or general well-being.
* Agreeing onward referrals and action plan.
* Written summary and plan sent to GP.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical or radiological diagnosis of minor stroke from a stroke consultant.
* Admitted to HASU or seen in rapid assessment/TIA clinic.
* Pre-admission mRS of 0-3 with no formal package of care prior to stroke.
* Discharge mRS of 0-3.
* No onward referral to community therapy team or for package of care.
* Has capacity to consent.
Exclusion Criteria
* Insufficient English to engage in intervention and outcome measures and no family or friends to support with this.
* Not resident in England.
* Pregnant women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College Healthcare NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Crow
Role: PRINCIPAL_INVESTIGATOR
Imperial College Healthcare NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Imperial CHN Trust
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23CX8211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.